Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00916929 · ClinicalTrials.gov registry record · NA
Detect Fluid Early From Intra-thoracic Impedance Monitoring
A NA study of Heart Failure, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- NA
- Development phase
- 162
- Enrollment target
- 20
- Study locations
NCT00916929: Completed NA study of Heart Failure, sponsored by Abbott Medical Devices.
NCT00916929 is a NA study of Heart Failure that has completed, run by Abbott Medical Devices. The registered enrollment target is 162 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00916929, a NA study of Heart Failure, has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- NA
- Development phase
- 162 participants
- Enrollment target
- 20
- Study locations
Study Summary
To demonstrate the safety and effectiveness of the Impedance Monitoring Feature in St Jude Medical cardiac devices.
Primary Outcome
False Positive Rate is the the number of departures from the device's programmed threshold that are unrelated to a heart failure event. The False Positive Rate per patient year of follow up should be less than 1.5.
Conditions Studied
Interventions
- DEVICE Impedance Monitoring Feature
Study Locations (20)
Florida
- Shands Jacksonville - Jacksonville
- Watson Clinic Center - Lakeland
- Orlando Heart Center - Orlando
- Tallahassee Research Institute - Tallahassee
Arkansas
- Arkansas Cardiology, PA - Little Rock
- Little Rock Cardiology Clinic, PA - Little Rock
California
- Glendale Memorial Hospital and MC - Glendale
- Cardiac Rhythm Specialists, Inc - Northridge
Michigan
- Cardiology Consultants of East Michigan - Flint
- Thoracic Cardiovascular HC Found. (Sparrow Research) - Lansing
Mississippi
- Hattiesburg Clinic - Hattiesburg
- North Mississippi Medical Center - Tupelo
New Jersey
- Deborah Heart and Lung Center - Browns Mills
- Associated Cardiovascular Consultants - Cherry Hill
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Arizona Arrhythmia Research Center - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-03 |
| Phase | NA |
What the finished NCT00916929 record still lists
NCT00916929 is an interventional study that assigns participants to a tested intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Impedance Monitoring Feature is the first listed.
NCT00916929 names 20 study sites across 12 states, led by Florida, Arkansas, California.
Frequently Asked Questions
What is clinical trial NCT00916929 about?
NCT00916929 is a clinical study titled "Detect Fluid Early From Intra-thoracic Impedance Monitoring". To demonstrate the safety and effectiveness of the Impedance Monitoring Feature in St Jude Medical cardiac devices.
What is the current status of trial NCT00916929?
This trial is currently completed. It is a NA study. The enrollment target is 162 participants. The study started on 2009-05. Estimated completion is 2012-03.
What conditions does trial NCT00916929 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT00916929?
The interventions under investigation include: Impedance Monitoring Feature (DEVICE).
Who is sponsoring clinical trial NCT00916929?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00916929 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00916929's enrollment target sits among peer trials
162 184th of 397 higher than 214 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia